By Counterforce Health Team in Elevidys (delandistrogene moxeparvovec-rokl) —

Get Elevidys Covered by Aetna (CVS Health) in Washington: Complete Eligibility Guide & Appeals Process

Quick Answer: Getting Elevidys Covered by Aetna in Washington

You can get Elevidys covered by Aetna (CVS Health) in Washington if you meet FDA eligibility criteria and follow their prior authorization process. Aetna requires precertification for this gene therapy, submitted at least two weeks before treatment. If denied, Washington's strong external review process through the Office of Insurance Commissioner gives you binding appeal rights. First step today: Contact your neuromuscular specialist to confirm DMD gene mutation status and anti-AAV antibody levels below 1:400, then gather documentation for Aetna's PA submission through Availity or Novologix portals.

Table of Contents

  1. Eligibility Requirements
  2. Prior Authorization Process
  3. Common Denial Reasons & Solutions
  4. Appeals Process in Washington
  5. Cost Support Options
  6. FAQ
  7. Sources & Further Reading

Eligibility Requirements

FDA Label Criteria for Elevidys

To qualify for Elevidys coverage, you must meet these FDA-approved criteria:

Requirement Details Verification Needed
Age 4 years or older Birth certificate or medical records
DMD Gene Mutation Confirmed mutation in DMD gene Genetic testing report
Excluded Variants No deletion in exon 8 and/or exon 9 Genetic analysis review
Anti-AAV Antibodies Titers below 1:400 Specialized antibody testing
Ambulatory Status Both ambulatory and non-ambulatory patients eligible Clinical assessment
Note: The anti-AAV antibody test is critical but no FDA-authorized test currently exists. Available tests may vary in accuracy, so work closely with your specialist on this requirement.

Aetna-Specific Requirements

Beyond FDA criteria, Aetna (CVS Health) requires:

  • Prior authorization (precertification) submitted at least two weeks before treatment
  • Treatment at designated centers meeting Aetna's network requirements
  • Complete medical documentation including diagnosis codes (ICD-10)
  • Detailed treatment plan with monitoring protocols

Prior Authorization Process

Step-by-Step Submission

1. Gather Required Documentation

  • Genetic testing confirming DMD mutation
  • Anti-AAV antibody test results
  • Complete medical history and current clinical status
  • Previous treatment attempts and outcomes
  • Prescriber's letter of medical necessity

2. Submit Through Official Channels Aetna accepts PA requests via:

  • Availity provider portal (most common)
  • Novologix for specialty drugs
  • Electronic Medical Record (EMR) systems
  • Fax or phone (backup options)

3. Timeline Expectations

  • Standard processing: Aetna approves over 95% of eligible authorizations within 24 hours with complete documentation
  • Missing information: Delays common if documentation incomplete
  • Appeals if denied: Multiple levels available in Washington

Clinician Corner: Medical Necessity Letter

Your prescriber's letter should include:

✓ Diagnosis confirmation: DMD with specific gene mutation details
✓ Clinical rationale: Why Elevidys is medically necessary now
✓ Prior treatments: History of attempted therapies and outcomes
✓ Safety considerations: Anti-AAV status and monitoring plan
✓ Treatment goals: Expected functional outcomes and timeline
✓ Guideline support: Reference to FDA approval and specialty guidelines

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"Investigational/Experimental" Cite FDA approval status (June 2024) FDA approval letter, prescriber attestation
Missing genetic confirmation Submit complete genetic testing DMD gene mutation report with excluded variants
Anti-AAV antibodies too high Retest if levels borderline; seek exception if medically appropriate Updated antibody titers, clinical justification
Not medically necessary Emphasize irreversible disease progression Functional assessments, progression documentation
Step therapy required Document contraindications or failures of alternatives Prior treatment records, intolerance documentation
Tip: Many initial denials are overturned with complete documentation. Don't be discouraged by a first denial—it's often due to missing paperwork rather than medical necessity.

Appeals Process in Washington

Washington state provides robust appeal rights through the Office of Insurance Commissioner (OIC).

Internal Appeals (Required First Step)

  1. First-level appeal: Submit within 180 days of denial
  2. Second-level appeal: Available if first level upheld
  3. Timeline: Aetna must respond within standard timeframes
  4. Documentation: Include all medical records, specialist letters, and FDA approval references

External Review (Independent Review Organization)

If internal appeals fail, Washington law guarantees external review:

Eligibility: Available after exhausting internal appeals
Timeline: Request within 4 months of final internal denial
Process: OIC assigns certified Independent Review Organization (IRO)
Decision: Binding on Aetna; standard reviews completed within 20-45 days
Expedited: 72 hours if delay would jeopardize health

How to Request External Review:

  1. Contact Aetna to initiate external review request
  2. Aetna forwards case to Washington OIC for IRO assignment
  3. Submit additional documentation directly to assigned IRO within 5 business days
  4. Await binding decision
From our advocates: We've seen families succeed in external review by emphasizing Elevidys's FDA approval status and the irreversible nature of DMD progression. One effective strategy is having the specialist clearly explain why delaying treatment even a few months could result in permanent functional decline that gene therapy cannot reverse.

When to Escalate Further

Contact the Washington Office of Insurance Commissioner if:

  • Aetna doesn't follow proper appeal procedures
  • Deadlines are missed by the insurer
  • You need help understanding your rights

Washington OIC Consumer Hotline: 800-562-6900
Online complaints: insurance.wa.gov

Cost Support Options

Even with insurance approval, out-of-pocket costs may be significant:

Manufacturer Support

  • Sarepta Therapeutics offers patient support programs
  • Financial assistance may be available based on income
  • Contact manufacturer directly for current programs

Additional Resources

  • Patient advocacy organizations: Parent Project Muscular Dystrophy provides insurance navigation support
  • State programs: Washington may have additional rare disease support
  • Copay assistance: Check if your plan qualifies for manufacturer copay cards

FAQ

How long does Aetna prior authorization take for Elevidys in Washington? Standard processing is within 24 hours for complete submissions. Incomplete documentation can cause delays of several days to weeks.

What if Elevidys isn't on Aetna's formulary? You can request a formulary exception with prescriber documentation showing medical necessity and lack of appropriate alternatives.

Can I request an expedited appeal in Washington? Yes, if treatment delay would seriously jeopardize your health. Expedited external reviews must be decided within 72 hours.

Does step therapy apply to Elevidys? Step therapy requirements vary by plan. Your prescriber can request an override if alternatives are contraindicated or have failed.

What happens if I move out of Washington during treatment? Coordinate with Aetna to ensure continued coverage. Appeal rights may differ in your new state.

How much does Elevidys cost? The list price is approximately $3.2 million for the one-time treatment. Insurance coverage and patient assistance programs significantly affect out-of-pocket costs.

Are there alternatives if Elevidys is denied? Discuss supportive DMD therapies with your specialist, including steroids and other FDA-approved treatments. Clinical trials may also be available.

Can I appeal a denial even if I don't live in Washington? This guide is specific to Washington residents with Aetna coverage. Appeal rights vary by state.

This comprehensive guide reflects the latest available information, but insurance policies and state regulations can change. For the most current requirements and assistance with your specific situation, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned to each plan's specific rules.

When facing complex prior authorization requirements or denials for specialty medications like Elevidys, having expert support can make the difference between approval and prolonged delays. Counterforce Health's platform ingests your denial letter and plan policy, identifies the specific denial basis, and creates comprehensive appeals with the right medical evidence and procedural requirements for your exact situation.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances, plan details, and current policies. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For questions about Washington insurance regulations, contact the Office of the Insurance Commissioner at 800-562-6900.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.